查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1465214

安氟烷市场：按途径、最终用途划分 - 2024-2030 年全球预测

Enflurane Market by Route of Administration (Inhalation, Oral), End-Use (Ambulatory Surgical Centers, Hospitals) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年安氟醚市场规模为2.0639亿美元，预计2024年将达2.157亿美元，2030年将达2.827亿美元，复合年增长率为4.59%。

安氟醚（化学名称：2-氯-1,1,2-三氟乙基二氟甲基醚）是一种吸入性麻醉剂，历史上曾在医学上用于诱导和维持全身麻醉。它的作用是调节中枢神经系统中各种神经传导物质系统的活动，导致可逆的意识和感觉丧失。安氟醚因其良好的药物动力学特征（包括起效和作用时间适中）而一度广泛用于外科手术，但由于安全性和有效性提高的新型药物的开发，其使用量随着时间的推移而减少。全球外科手术的增加、医疗实践的进步以及医疗保健基础设施的大量投资推动了对安氟醚的需求。儘管面临严格的监管标准、潜在副作用以及来自安全性更高的新型麻醉剂的竞争等挑战，安氟醚市场仍提供了充满希望的成长机会。这包括探索减少副作用的先进、安全的麻醉剂配方，利用资料分析和人工智慧等技术创新进行精确剂量，以及扩展到医疗保健标准不断提高的新兴市场。专注于环保替代品和奈米技术用于靶向药物传输的潜在整合的研究和创新预计将加强市场成长轨迹，同时解决环境问题并改善患者的治疗结果。

主要市场统计
基准年[2023] 20639万美元
预测年份 [2024] 2.157 亿美元
预测年份 [2030] 2.827 亿美元
复合年增长率（%） 4.59%

给药途径：经由吸入增加安氟烷给药量

安氟醚主要透过吸入给药。一种强效吸入麻醉剂，用于诱导及维持全身麻醉。当透过吸入给药时，安氟烷直接从呼吸系统吸收，可以快速诱导麻醉。此途径是优选的，因为它可以在手术过程中更好地控制麻醉深度。仔细监测呼吸功能和麻醉剂浓度对于确保病人安全和有效的麻醉管理至关重要。安氟醚有口服给药途径。可以开处方或建议口服安氟醚。口服摄入为充分麻醉提供了适当的机制。

最终用途：改进安氟醚在医院的使用方式

由于新型、肝毒性较小且代谢快速的吸入麻醉剂的开发，安氟烷在门诊手术中心较少使用。然而，不能完全排除安氟醚在资源匮乏地区和某些患者群体中的作用。在这些机构中，患者的早期復健和出院是首要任务，因此应使用能快速从体内清除且术后副作用最小的麻醉剂。医院是使用安氟醚的主要场所，特别是在更专业的外科或加护病房病房，可以密切监测其使用情况。由于其功效和成本效益，在某些情况下可以选择安氟烷。由于担心肾毒性和可能诱发癫痫发作，特别是在易患癫痫的患者中，安氟醚的受欢迎程度有所下降，特别是由于新药价格昂贵或无法获得，在一些国家，它仍然被用作麻醉剂武器。

区域洞察

由于医疗基础设施强大、人均医疗成本高以及重视需要全身麻醉的外科手术，安氟醚在美洲拥有庞大的市场。在欧盟（EU），成员国之间医疗保健政策的差异正在影响安氟醚的市场渗透率。政府在医疗保健方面支出较高的国家在麻醉方案中使用安氟醚的比例较高。 EMEA（欧洲、中东和非洲）地区拥有多元化的市场，从拥有先进医疗设施的石油国家到医疗基础设施有限的新兴经济体。在没有财力的地区，麻醉剂的使用可能不会有进展。在亚太地区，由于医疗产业的快速扩张和外科手术的激增，安氟烷市场正在不断发展。印度安氟醚市场受到医疗保健基础设施成长、医疗保健设施使用改善以及成本敏感性的影响。负担能力和功效之间的平衡对于安氟醚在印度市场的普及起着关键作用。

FPNV定位矩阵

FPNV定位矩阵对于评估安氟醚市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对安氟醚市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1. 安氟烷市场规模和预测是多少？

2.安氟烷市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些？

3. 安氟烷市场的技术趋势和法规结构是什么？

4.安氟醚市场主要厂商的市场占有率是多少？

5.进入安氟醚市场的合适型态和战略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球慢性病和事故的发生率正在增加
      • 安氟烷越来越受到麻醉师用于需要短期至中期麻醉的手术的青睐
    • 抑制因素
      • 新型先进麻醉剂的出现
    • 机会
      • 麻醉管理和监测技术的创新
      • 正在进行生物分解性和环保替代品的研究
    • 任务
      • 安氟烷使用的监管监督和严格指南
  • 市场区隔分析
    • 给药途径：经由吸入增加安氟醚的剂量
    • 最终用途：医院使用安氟烷方式的演变
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章 安氟醚市场：依给药途径

  • 吸入
  • 口服

第七章 安氟醚市场：依最终用途

  • 门诊手术中心
  • 医院

第八章 美洲安氟醚市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区安氟烷市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲安氟醚市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • SunMed 完成对 Viair Medical 呼吸和麻醉耗材业务的收购
  • 战略分析和建议

第12章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-F97DD5A7D999

[180 Pages Report] The Enflurane Market size was estimated at USD 206.39 million in 2023 and expected to reach USD 215.70 million in 2024, at a CAGR 4.59% to reach USD 282.70 million by 2030.

Enflurane, chemically designated as 2-chloro-1,1,2-trifluoroethyl difluoromethyl ether, is an inhalational anesthetic historically utilized in medicine to induce and maintain general anesthesia. It operates by modulating the activity of various neurotransmitter systems in the central nervous system, leading to a reversible loss of consciousness and sensation. While enflurane was once widely used in surgical settings for its advantageous pharmacokinetic profile, including a moderate onset and duration of action, its application has diminished over time due to the development of newer agents with improved safety and efficacy profiles. Enflurane's need is driven by the increasing number of surgical interventions worldwide, advancements in medical practices, and significant investments in healthcare infrastructure. Despite facing challenges such as stringent regulatory standards, potential side effects, and competition from newer anesthetics with improved safety profiles, the enflurane market holds promising growth opportunities. These include the exploration of advanced, safer anesthetic formulations with reduced side effects, leveraging technological innovations such as data analytics and AI for precision dosing, and expanding into emerging markets with rising healthcare standards. Research and innovation focusing on eco-friendly alternatives and the potential integration of nanotechnology for targeted drug delivery represent transformative directions for enhancing the market's growth trajectory while addressing environmental concerns and improving patient outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 206.39 million
Estimated Year [2024] USD 215.70 million
Forecast Year [2030] USD 282.70 million
CAGR (%) 4.59%

Route of Administration: Increasing administration of enflurane via inhalation

Enflurane is primarily administered through inhalation. It is a potent inhalational anesthetic agent for general anesthesia induction and maintenance. Inhalation administration allows enflurane to be directly absorbed through the respiratory system, providing a rapid onset of anesthesia. This route is preferred for its controllability and the capacity to adjust the depth of anesthesia during surgical procedures. Careful monitoring of respiratory function and anesthetic concentration is critical to ensure patient safety and effective anesthesia management. The oral route of administration is applicable for enflurane. Enflurane is sometimes formulated or recommended for oral consumption. Oral consumption provides an appropriate mechanism for adequate anesthesia.

End-Use: Evolving usage of enflurane by hospitals

In ambulatory surgical centers, enflurane is infrequently used due to the development of newer, less hepatotoxic, and more rapidly metabolized inhalational anesthetics. However, its role in certain low-resource settings or specific patient populations cannot be entirely discounted. These centers prioritize quick patient recovery and discharge, necessitating using anesthetics that allow rapid clearance from the body and minimal post-operative side effects. Hospitals represent a primary setting for administering enflurane, particularly in more specialized surgical or intensive care units where its use can be closely monitored. Enflurane may be chosen for its potency and cost-effectiveness in specific scenarios. Despite its declining popularity due to concerns over nephrotoxicity and the potential for seizure induction, especially in patients predisposed to epilepsy, it remains in the arsenal of anesthetics, particularly in countries where newer agents are prohibitively expensive or unavailable.

Regional Insights

In the Americas, enflurane has a significant market driven by robust healthcare infrastructure, high per capita healthcare expenditure, and a strong emphasis on surgical procedures requiring general anesthesia. In the European Union, varying healthcare policies across member states affect enflurane's market penetration. Nations with more significant governmental healthcare spending exhibit higher rates of enflurane utilization in anesthesia protocols. The EMEA region presents a diverse market ranging from oil-rich nations with advanced healthcare facilities to developing economies with limited medical infrastructure. Affordability issues may drive its use in less affluent areas. In the Asia Pacific, the enflurane market is evolving due to the rapidly expanding healthcare sector and surge in surgical procedures. India's market for enflurane is influenced by its growing healthcare infrastructure, increased accessibility to medical facilities, and cost sensitivity. The balance between affordability and efficacy plays a critical role in enflurane's adoption in the Indian market.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Enflurane Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Enflurane Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Enflurane Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Baxter International, Inc., Boehringer Ingelheim International GmbH, Dragerwerk AG & Co. KGaA, GE HealthCare Technologies Inc., Hikma Pharmaceuticals PLC, J&TEC CO., LTD., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Enflurane Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Route of Administration
    • Inhalation
    • Oral
  • End-Use
    • Ambulatory Surgical Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Enflurane Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Enflurane Market?

3. What are the technology trends and regulatory frameworks in the Enflurane Market?

4. What is the market share of the leading vendors in the Enflurane Market?

5. Which modes and strategic moves are suitable for entering the Enflurane Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of chronic diseases and accidents globally
      • 5.1.1.2. Increasing preference for enflurane among anesthesiologists for surgeries requiring short- to medium-term anesthesia
    • 5.1.2. Restraints
      • 5.1.2.1. Emergence of newer and advanced anesthetic agents
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological innovations in anesthesia delivery and monitoring techniques
      • 5.1.3.2. Ongoing research into biodegradable, eco-friendly alternatives
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory scrutiny and stringent guidelines governing the use of enflurane
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Route of Administration: Increasing administration of enflurane via inhalation
    • 5.2.2. End-Use: Evolving usage of enflurane by hospitals
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Enflurane Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Inhalation
  • 6.3. Oral

7. Enflurane Market, by End-Use

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals

8. Americas Enflurane Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Enflurane Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Enflurane Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. SunMed Completes Acquisition Of Respiratory & Anesthesia Consumables Business Of Vyaire Medical
  • 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. ENFLURANE MARKET RESEARCH PROCESS
  • FIGURE 2. ENFLURANE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ENFLURANE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ENFLURANE MARKET DYNAMICS
  • FIGURE 7. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ENFLURANE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. ENFLURANE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ENFLURANE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ENFLURANE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL ENFLURANE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL ENFLURANE MARKET SIZE, BY INHALATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL ENFLURANE MARKET SIZE, BY INHALATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL ENFLURANE MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL ENFLURANE MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. AMERICAS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 20. AMERICAS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 21. AMERICAS ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 22. AMERICAS ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 23. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 24. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 26. ARGENTINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 28. ARGENTINA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 29. BRAZIL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 30. BRAZIL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 31. BRAZIL ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 32. BRAZIL ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 33. CANADA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 34. CANADA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 35. CANADA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 36. CANADA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 37. MEXICO ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 38. MEXICO ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 39. MEXICO ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 40. MEXICO ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 41. UNITED STATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 42. UNITED STATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 43. UNITED STATES ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 44. UNITED STATES ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 46. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 54. AUSTRALIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 56. AUSTRALIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 57. CHINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 58. CHINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 59. CHINA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 60. CHINA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 61. INDIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 62. INDIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 63. INDIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 64. INDIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 65. INDONESIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 66. INDONESIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 67. INDONESIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 68. INDONESIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 69. JAPAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 70. JAPAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 71. JAPAN ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 72. JAPAN ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 73. MALAYSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 74. MALAYSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 75. MALAYSIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 76. MALAYSIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 78. PHILIPPINES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 80. PHILIPPINES ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 81. SINGAPORE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 82. SINGAPORE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 83. SINGAPORE ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 84. SINGAPORE ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 86. SOUTH KOREA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 88. SOUTH KOREA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 89. TAIWAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 90. TAIWAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 91. TAIWAN ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 92. TAIWAN ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 93. THAILAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 94. THAILAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 95. THAILAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 96. THAILAND ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 97. VIETNAM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 98. VIETNAM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 99. VIETNAM ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 100. VIETNAM ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 107. DENMARK ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 108. DENMARK ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 109. DENMARK ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 110. DENMARK ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 111. EGYPT ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 112. EGYPT ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 113. EGYPT ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 114. EGYPT ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 115. FINLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 116. FINLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 117. FINLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 118. FINLAND ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 119. FRANCE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 120. FRANCE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 121. FRANCE ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 122. FRANCE ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 123. GERMANY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 124. GERMANY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 125. GERMANY ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 126. GERMANY ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 127. ISRAEL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 128. ISRAEL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 129. ISRAEL ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 130. ISRAEL ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 131. ITALY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 132. ITALY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 133. ITALY ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 134. ITALY ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 136. NETHERLANDS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 138. NETHERLANDS ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 139. NIGERIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 140. NIGERIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 141. NIGERIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 142. NIGERIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 143. NORWAY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 144. NORWAY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 145. NORWAY ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 146. NORWAY ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 147. POLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 148. POLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 149. POLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 150. POLAND ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 151. QATAR ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 152. QATAR ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 153. QATAR ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 154. QATAR ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 155. RUSSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 156. RUSSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 157. RUSSIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 158. RUSSIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 160. SAUDI ARABIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 162. SAUDI ARABIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 164. SOUTH AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 167. SPAIN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 168. SPAIN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 169. SPAIN ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 170. SPAIN ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 171. SWEDEN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 172. SWEDEN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 173. SWEDEN ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 174. SWEDEN ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 176. SWITZERLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 178. SWITZERLAND ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 179. TURKEY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 180. TURKEY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 181. TURKEY ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 182. TURKEY ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 188. UNITED KINGDOM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 190. UNITED KINGDOM ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 191. ENFLURANE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. ENFLURANE MARKET, FPNV POSITIONING MATRIX, 2023